To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of extending eligibility for the Autumn 2025 COVID-19 vaccination to individuals under the age of 75 who, while not classified as immunosuppressed, have (a) COPD, (b) limited mobility and (c) other chronic health conditions that may increase their vulnerability to serious illness.

The Government is committed to protecting those most vulnerable to COVID-19 through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The primary aim of the national COVID-19 vaccination programme remains the prevention of serious illness, resulting in hospitalisations and deaths, arising from COVID-19.

The JCVI has advised that population immunity to COVID-19 has been increasing due to a combination of naturally acquired immunity following recovery from infection and vaccine-derived immunity. COVID-19 is now a relatively mild disease for most people, though it can still be unpleasant, with rates of hospitalisation and death from COVID-19 having reduced significantly since COVID-19 first emerged.

The focus of the JCVI advised programme has therefore moved towards targeted vaccination of the two groups who continue to be at higher risk of serious disease, including mortality. These are the oldest adults and individuals who are immunosuppressed. The Government has accepted the JCVI’s advice for autumn 2025 and in line with the advice, a COVID-19 vaccination is being offered to the following groups:

- adults aged 75 years old and over;

- residents in care homes for older adults; and

- individuals aged six months and over who are immunosuppressed.

As for all vaccines, the JCVI keeps the evidence under regular review.